This is a Scorecard review, revisiting a past LF0 research call against what actually happened.
Ticker: GTN Rating: Sell Published: 2026-08-20 Checkpoint: 2026-09-20 Entry price: $4.83 Latest price: $4.44 as of 2026-09-18 Stock return since entry: -8.1% Signal return: +8.1% Verdict: Correct so far
This is the 1-month checkpoint for this call. LF0 publishes monthly Scorecard updates through month 6, using the closest available daily close on or before the checkpoint date.
Read the original LF0 analysis
What I Said
I rated GTN a Sell because I thought the operating rebound was real, but the balance sheet was still too stretched to make the equity look safely mispriced. My original focus was on the 30.1% TTM FCF yield and $155.1M of levered free cash flow on one side, versus $5.9B of debt and 8.3x net debt/EBITDA on the other, with 7.0x net debt/EBITDA as the level that would start to change my mind.
Peer Comparison
| Company | Return Since Entry |
|---|---|
| GTN (this call) | -8.1% |
| AMCX | -5.5% |
| IHRT | -18.5% |
| SGA | -3.2% |
| SSP | -8.2% |
| TSQ | -8.5% |
Why It’s Working (Or Not)
So far, following my Sell has worked: the stock is down about 8.1%, which means a short would be up the same amount over this window. That outcome is consistent with my view that the leverage overhang mattered more than the revenue rebound, and the peer set has also been mostly lower, so GTN has not stood out as a clear outlier against similarly pressured names. What I can say with confidence is that the specific risk I highlighted — a heavy debt load and refinancing sensitivity — has not been disproven by the price action. What I cannot say yet is that the thesis has been fully validated on fundamentals, because I have not been given new leverage or cash-flow data showing net debt/EBITDA has actually moved toward my 7.0x threshold.
What Could Still Prove Me Wrong
If GTN can show that net debt/EBITDA is falling materially toward or below 7.0x while EBITDA stays near the $190M-$200M range I cited, that would weaken my bearish case. I would also be forced to reconsider if operating cash flow holds up instead of slipping back toward the $250M TTM level I flagged as a danger zone. Until then, the main thing that could prove me wrong is evidence that the balance sheet is de-risking faster than the business is merely rebounding.
The August 2026 Cohort
Other directional calls published the same month:
| Ticker | Rating | Entry | Latest | Stock Return | Signal Return | Verdict |
|---|---|---|---|---|---|---|
| SDGR | Sell | $17.40 | $29.02 | +66.8% | -66.8% | Incorrect so far |
| WGS | Sell | $77.88 | $101.10 | +29.8% | -29.8% | Incorrect so far |
| ALT | Sell | $3.15 | $3.25 | +3.2% | -3.2% | Incorrect so far |
| VNOM | Sell | $41.67 | $42.27 | +1.4% | -1.4% | Incorrect so far |
| AES | Sell | $14.71 | $14.83 | +0.8% | -0.8% | Incorrect so far |
| SPHR | Sell | $147.34 | $145.19 | -1.5% | +1.5% | Correct so far |
| STXS | Sell | $1.39 | $1.33 | -4.3% | +4.3% | Correct so far |
| NNDM | Sell | $1.65 | $1.57 | -4.8% | +4.8% | Correct so far |
| LHX | Sell | $260.92 | $247.29 | -5.2% | +5.2% | Correct so far |
| BA | Sell | $210.46 | $198.20 | -5.8% | +5.8% | Correct so far |
| ADTN | Sell | $7.76 | $7.20 | -7.2% | +7.2% | Correct so far |
| NXE | Sell | $10.40 | $9.35 | -10.1% | +10.1% | Correct so far |
| OI | Sell | $6.79 | $6.07 | -10.6% | +10.6% | Correct so far |
| NUTX | Buy | $188.41 | $208.79 | +10.8% | +10.8% | Correct so far |
| PENN | Sell | $18.56 | $16.45 | -11.4% | +11.4% | Correct so far |
| LRCX | Sell | $343.84 | $288.11 | -16.2% | +16.2% | Correct so far |
| SRG | Strong Sell | $2.11 | $1.88 | -10.9% | +16.4% | Correct so far |
| OWLT | Sell | $5.81 | $4.74 | -18.4% | +18.4% | Correct so far |
| RRGB | Sell | $9.51 | $7.05 | -25.9% | +25.9% | Correct so far |
Live LF0 scorecard: The Scorecard | Research Performance dashboard
Past performance does not guarantee future results. Nothing here is investment advice or a recommendation to buy or sell securities. Returns use LF0’s daily-close scorecard methodology.
Leave a Comment